ALLIANCEBERNSTEIN L.P. - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 129 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,455,697
-34.3%
87,272
+8.8%
0.00%0.0%
Q2 2023$2,215,124
+77.7%
80,200
+48.0%
0.00%0.0%
Q1 2023$1,246,600
+110.8%
54,2000.0%0.00%
Q4 2022$591,322
+75.5%
54,200
+35.5%
0.00%
Q3 2022$337,000
-7.4%
40,000
-13.0%
0.00%
Q2 2022$364,000
-87.8%
46,000
-63.6%
0.00%
-100.0%
Q1 2022$2,995,000
+90.8%
126,463
+175.5%
0.00%0.0%
Q4 2021$1,570,000
+93.1%
45,9000.0%0.00%
Q3 2021$813,000
-60.5%
45,9000.0%0.00%
-100.0%
Q2 2021$2,060,000
+159.8%
45,900
+50.0%
0.00%
Q1 2021$793,000
+40.6%
30,600
+9.3%
0.00%
Q4 2020$564,000
+3.1%
28,0000.0%0.00%
Q3 2020$547,000
+10.7%
28,0000.0%0.00%
Q2 2020$494,000
+333.3%
28,000
+73.9%
0.00%
Q1 2020$114,000
+28.1%
16,100
+27.8%
0.00%
Q4 2019$89,000
-41.1%
12,6000.0%0.00%
Q3 2019$151,00012,6000.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$56,331,20918.32%
Kynam Capital Management, LP 1,375,000$31,625,0004.08%
BVF INC/IL 3,775,900$86,845,7003.18%
Cormorant Asset Management, LP 1,700,000$39,1002.58%
RTW INVESTMENTS, LP 4,600,799$105,818,3772.20%
Ghost Tree Capital, LLC 225,000$5,175,0001.53%
683 Capital Management, LLC 791,000$18,193,0001.36%
Ikarian Capital, LLC 211,400$4,862,2001.10%
Ikarian Capital, LLC 211,400$4,862,2001.10%
SILVERARC CAPITAL MANAGEMENT, LLC 105,486$2,426,1781.00%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders